ARTICLE | Company News
Infinity, Novartis cancer deal
March 7, 2006 3:32 AM UTC
Infinity ( Cambridge, Mass.) partnered with Novartis (NVS; SWX:NOVN) to discover, develop and commercialize Bcl-2 and Bcl-xl inhibitors to treat cancer. The deal includes preclinical compounds from In...